SCHEMBL11385250

SCHEMBL11385250

CN=C(NCCSCc1nc[nH]c1C)NCCSCc1nc[nH]c1C

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC47A1 Q96FL8 2/20 0.80
▸ HRH2 P25021 2/20 0.80
▸ SMN1; SMN2 Q16637 2/20 0.80
▸ MEN1 O00255 1/20 0.80
▸ SLC22A2 O15244 1/20 0.80
▸ LMNA P02545 1/20 0.80
▸ CYP1A2 P05177 1/20 0.80
▸ GLA P06280 1/20 0.80
▸ CYP3A4 P08684 1/20 0.80
▸ CYP2D6 P10635 1/20 0.80
▸ TSHR P16473 1/20 0.80
▸ ATP4A P20648 1/20 0.80
▸ APEX1 P27695 1/20 0.80
▸ PDE4A P27815 1/20 0.80
▸ CYP2C19 P33261 1/20 0.80
▸ ADRA1A P35348 1/20 0.80
▸ ATP4B P51164 1/20 0.80
▸ KMT2A Q03164 1/20 0.80
▸ SLC47A2 Q86VL8 1/20 0.80
▸ SLC22A8 Q8TCC7 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10852820 0.96 SLC47A1 (0.74) SLC47A1HRH2SMN1; SMN2MEN1SLC22A2
Hydrochloric Acid SCHEMBL11381235 0.92 SLC47A1 (0.73) SLC47A1HRH2SMN1; SMN2MEN1SLC22A2
SCHEMBL11163179 0.91 SLC47A1 (0.67) SLC47A1HRH2SMN1; SMN2MEN1SLC22A2
Cimetidine SCHEMBL534523 0.89 CYP3A4 (1.00) SLC47A1HRH2SMN1; SMN2MEN1SLC22A2
Cimetidine SCHEMBL3735476 0.89 CYP3A4 (1.00) SLC47A1HRH2SMN1; SMN2MEN1SLC22A2
Cimetidine SCHEMBL226031 0.89 CYP3A4 (1.00) SLC47A1HRH2SMN1; SMN2MEN1SLC22A2
SCHEMBL14175415 0.89 HRH2 (0.79) SLC47A1HRH2SMN1; SMN2MEN1SLC22A2
Cimetidine SCHEMBL1736444 0.88 CYP3A4 (0.98) SLC47A1HRH2SMN1; SMN2MEN1SLC22A2
Cimetidine SCHEMBL22127097 0.88 CYP3A4 (0.98) SLC47A1HRH2SMN1; SMN2MEN1SLC22A2
Cimetidine SCHEMBL1736443 0.88 CYP3A4 (0.98) SLC47A1HRH2SMN1; SMN2MEN1SLC22A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4107319-A GUANIDINES, BLOCKING AGENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1978-08-15 — — US claimed
US-4282234-A HISTAMINE BLOCKING AGENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1981-08-04 — — US disclosed
US-4282234-A HISTAMINE BLOCKING AGENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1981-08-04 — — US disclosed
US-4191769-A HISTAMINE ANTAGONISTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1980-03-04 — — US disclosed
US-4191769-A HISTAMINE ANTAGONISTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1980-03-04 — — US disclosed
US-4170652-A USED TO BLOCK HISTAMINE H2 RECEPTORS ANTISECRETORY, ANTIINFLAMMATORY SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1979-10-09 — — US disclosed
US-4170652-A USED TO BLOCK HISTAMINE H2 RECEPTORS ANTISECRETORY, ANTIINFLAMMATORY SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1979-10-09 — — US disclosed
US-4118496-A HISTAMINE H2-ANTAGONISTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1978-10-03 — — US disclosed
US-4118496-A HISTAMINE H2-ANTAGONISTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1978-10-03 — — US disclosed
US-4109003-A N-(IMIDAZOLYL-METHYLTHIO-ALKYL) DERIVATIVES OF S-ALKYL ISOTHIOUREAS; ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1978-08-22 — — US disclosed
US-4109003-A N-(IMIDAZOLYL-METHYLTHIO-ALKYL) DERIVATIVES OF S-ALKYL ISOTHIOUREAS; ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1978-08-22 — — US disclosed
US-4107319-A GUANIDINES, BLOCKING AGENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1978-08-15 — — US disclosed
US-4107319-A GUANIDINES, BLOCKING AGENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1978-08-15 — — US disclosed
US-4036971-A HISTAMINE H(2) ANTAGONISTS SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1977-07-19 — — US disclosed
Send feedback